Presbyterian Hospital of Dallas TexasOncology@PresbyterianHosp — Dallas, Texas

Presbyterian Hospital of Dallas TexasOncology@PresbyterianHosp is a clinical research site located in Dallas, Texas, United States 75231.

Crixeo Clinical Trials Trust Score: 95/100 (GOOD). This profile has not yet been claimed by the site owner.

Presbyterian Hospital of Dallas TexasOncology@PresbyterianHosp has participated in 2 clinical trials.

Therapeutic areas: Breast Cancer, Chronic Myelogenous Leukemia.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Dallas

Browse all research sites in Texas · View every site in Dallas

Sponsor Feasibility Report

Trust Score: 95/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Presbyterian Hospital of Dallas TexasOncology@PresbyterianHosp?

Presbyterian Hospital of Dallas TexasOncology@PresbyterianHosp has a Crixeo Trust Score of 95/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Presbyterian Hospital of Dallas TexasOncology@PresbyterianHosp conducted?

Presbyterian Hospital of Dallas TexasOncology@PresbyterianHosp has 2 clinical trials on record. Their work covers Breast Cancer, Chronic Myelogenous Leukemia.

Is Presbyterian Hospital of Dallas TexasOncology@PresbyterianHosp accredited by Crixeo Clinical Trials?

Presbyterian Hospital of Dallas TexasOncology@PresbyterianHosp has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Presbyterian Hospital of Dallas TexasOncology@PresbyterianHosp?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.